Join Us for Lewy Body Dementia, Parkinson’s & Alzheimer’s: Treatments & Diagnosis
Wednesday, April 9 3:00 pm – 4:00 pm. Click HERE to RSVP!

Lewy Body Dementia, Parkinson's & Alzheimer's: Treatments & Diagnosis

09apr3:00 pm4:00 pmLewy Body Dementia, Parkinson's & Alzheimer's: Treatments & DiagnosisWhat You Need to Know from a Clinical & Caregiver Perspective

Event Details

REGISTER HERE

Caring for a loved one with dementia can be overwhelming, especially as memory loss and cognitive changes impact daily life. While all dementias share similarities, each type has distinct causes, symptoms, and progression. Join us for an informative session where we’ll explore the key differences and overlaps between Lewy-Body Dementia, Alzheimer’s, and Parkinson’s disease.

Learn what steps you can take to best support your loved one, including the latest treatment options available. We’ll also discuss Leqembi®, the FDA-approved drug designed to help slow the progression of early-stage Alzheimer’s. In addition to gaining valuable insights from experts, you’ll have the opportunity to connect with others facing similar challenges, share experiences, and build a supportive network.

Meet Our Speakers

Keith N. Fargo, PhD, is the Director of Scientific Initiatives at the Lewy Body Dementia Association. Dr. Fargo earned his PhD in Neuroscience from Indiana University, where his research focused on the effects of hormones on the structure and function of spinal cord neurons that control movement. In his current role at the Lewy Body Dementia Association, he is responsible for the research activities of the LBDA, including the flagship LBDA Research Centers of Excellence, a network of 20 of the nation’s leading academic medical institutions focused on advancing our understanding of the disease, improving care, and carrying out clinical trials for Lewy body dementias.

Connor D. Courtney, PhD of Northwestern University Feinberg School of Medicine, Associate Director of Research Programs at the Parkinson’s Foundation, received a Postdoctoral Fellowship grant to study a part of the brain that plays a key role in Parkinson’s disease (PD) motor symptoms. Dr. Courtney attributes his motivation to study Parkinson’s disease to his father, who currently lives with PD. “As an issue with tremendous personal relevance, my overarching aspiration is to take my deep passion for neuroscience and apply it to the study of PD.”

Claire Day, Chief Program Officer at the Alzheimer’s Association, has been on staff at the Alzheimer’s Association since 2001. She is the Chief Program Officer at the Northern California & Northern Nevada Chapter and as such, oversees all care and support operations and research initiatives. Claire Day is a clinical social worker and received her degree from Bloomsburg University of Pennsylvania. She has more than twenty years of experience as a family and professional educator in dementia care and has authored two forwards to Alzheimer’s caregiver books.

Together, we can navigate this journey with knowledge, care, and community. Don’t Miss this insightful virtual event!

In partnership with:

Time

April 9, 2025 3:00 pm - 4:00 pm PDT(GMT-07:00)

Location

Virtual Zoom Event

Other Events

Organizer

Nikki Zbihley

Director of Community Outreach

Learn More